Document is current
Any future updates will be listed below
-
Authors
Al Tawil, Amani
McGrath, Sean
Ristl, Robin
Mansmann, Ulrich
-
Funding
Funding for this research was provided by:
National Science Foundation Graduate Research Fellowship Program (DGE 2140743)
Ludwig-Maximilians-Universität München
- License Information
-
More Information
Article History
Received: 17 March 2024
Accepted: 3 December 2024
First Online: 20 December 2024
Declarations
:
: The ALTA-1L trial was conducted in accordance with the principles of the Declaration of Helsinki and the International Council for Harmonization guidelines for good clinical practice. Written informed consent was obtained from all study participants for data sharing. For our research work, we submitted a waiver approval to the Ethics Committee at the University of Munich. The committee thoroughly evaluated the provided documentation and information to ensure adherence to the ethical principles outlined in the Declaration of Helsinki, Section 15 of the professional code, and faculty law. The Ethics Committee approved the study (Project No.: 22-0934) and raised no objections to its conduct.
: Not applicable.
: The authors declare no competing interests.
